(Q34269084)

1 August 2017

Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers (English)

1 reference

1 August 2017

Plasma Kinetics, Metabolism, and Urinary Excretion of Alpha‐Lipoic Acid following Oral Administration in Healthy Volunteers (English)

1 reference

https://api.crossref.org/works/10.1177/0091270003258654

20 March 2024

1 reference

https://api.crossref.org/works/10.1177/0091270003258654

20 March 2024

2

Robert Hermann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14551180

20 March 2024

author name string

Jens Teichert

1

1 reference

1 August 2017

Peter Ruus

3

1 reference

1 August 2017

Rainer Preiss

4

1 reference

1 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14551180

20 March 2024

publication date

1 November 2003

1 reference

full work available at URL

1 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1177%2F0091270003258654

1 reference

https://api.crossref.org/works/10.1177/0091270003258654

https://accp1.onlinelibrary.wiley.com/doi/pdf/10.1177/0091270003258654

20 March 2024

1 reference

https://api.crossref.org/works/10.1177/0091270003258654

The Journal of Clinical Pharmacology

20 March 2024

published in

1 reference

1 August 2017

43

1 reference

1 August 2017

11

1 reference

1 August 2017

1257-1267

1 reference

Alpha-lipoic acid reduction by mammalian cells to the dithiol form, and release into the culture medium

1 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

Cytosolic and mitochondrial systems for NADH- and NADPH-dependent reduction of alpha-lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

A method for measuring disulfide reduction by cultured mammalian cells: relative contributions of glutathione-dependent and glutathione-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

Antioxidant activities of dihydrolipoic acid and its structural homologues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

alpha-Lipoic acid as a biological antioxidant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

Sulfur-centered radical formation from the antioxidant dihydrolipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

Idiopathic dysgeusia; an open trial of alpha lipoic acid (ALA) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

Dose-proportionality of oral thioctic acid--coincidence of assessments via pooled plasma and individual data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

The metabolism of dl-[1, 6-14C]lipoic acid in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

High-performance liquid chromatographic assay for alpha-lipoic acid and five of its metabolites in human plasma and urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003258654

Glutathione reductase and lipoamide dehydrogenase have opposite stereospecificities for alpha-lipoic acid enantiomers

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1177/0091270003258654

Reduction of lipoic acid by lipoamide dehydrogenase

20 March 2024

3

1 reference

https://api.crossref.org/works/10.1177/0091270003258654

Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)

20 March 2024

12

1 reference

https://api.crossref.org/works/10.1177/0091270003258654

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy

20 March 2024

14

1 reference

https://api.crossref.org/works/10.1177/0091270003258654

Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy

20 March 2024

15

1 reference

https://api.crossref.org/works/10.1177/0091270003258654

Gastric emptying in patients with insulin dependent diabetes mellitus and bioavailability of thioctic acid-enantiomers

20 March 2024

24

1 reference

https://api.crossref.org/works/10.1177/0091270003258654

Influence of food intake on the bioavailability of thioctic acid enantiomers

20 March 2024

25

1 reference

https://api.crossref.org/works/10.1177/0091270003258654

Lipoic acid metabolism in the rat

20 March 2024

27

1 reference

https://api.crossref.org/works/10.1177/0091270003258654

20 March 2024

Identifiers

1 reference

1 August 2017

1 reference